Major Gift Will Endow a Program Devoted to a Fuller Understanding of How the Human Brain Works
The Thomas Kingsley Lawrence ’19 Program in Brain Research will take a multifaceted approach to understanding the higher-order functionality of the human brain and related areas. It is hoped that with the knowledge gained, novel prevention strategies, diagnostics, and therapeutics to reduce the incidence, prevalence, and recurrence of psychiatric disorders will be possible.
Spreading HAPPINESS in Nigeria: Yale, Partners Expand Mental Health Program
On Jan. 17, during a four-day trip to Nigeria that is part of the Yale Africa Initiative, Yale President Peter Salovey met with officials to finalize plans for expanding the HAPPINESS Project, a program of the Yale Department of Psychiatry.
Yale Study: Ketamine Disinhibits Dendrites and Enhances Calcium Signals in Prefrontal Dendritic Spines
In a study published in Nature Communications, Alex Kwan, PhD, Associate Professor of Psychiatry, and his research team found that within an hour after a mouse received ketamine, there is a substantial increase in the amount of calcium that goes into the dendritic spines for neurons in the prefrontal cortex.
Yale Psychiatry to Launch Public Psychiatry Track
The Yale Department of Psychiatry is creating a new track for residents who are interested in the field of Public/Community Psychiatry, broadly defined as the treatment of individuals with serious mental illness and substance use disorders who receive services supported by public funds.
Yale Review: How Brain Alterations Contribute to Suicidal Thoughts and Behaviors
How brain alterations contribute to suicidal thoughts and behaviors is the subject of a new published review of brain scanning studies by Yale and international researchers. Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience, and Professor of Psychiatry, in the Child Study Center and of Radiology and Biomedical Imaging at Yale, is the paper's lead and corresponding author.
Buono Will Lobby Congress to Increase Funding for Neurofibromatosis
Frank D. Buono, PhD, Associate Research Scientist in Psychiatry, will lobby members of Congress on behalf of several advocacy groups in Washington, D.C. in February 2020 to increase funding for the rare genetic disease called Neurofibromatosis (NF).
Study Suggests Role for Targeting Psychological Variables in the Treatment of Opioid Use Disorder and Chronic Pain
There is a paucity of evidence-based treatments for co-occurring opioid use disorder and chronic pain. These inter-related chronic medical conditions have been central to the unfolding of the opioid crisis. A new study by researchers at Yale, Johns Hopkins, University of Bridgeport, and Western Connecticut State University published in the Journal of Clinical Psychology suggests that psychological variables are important treatment targets for co-occurring opioid use disorder and chronic pain.
Ensler to Give Keynote Speech at Women's Mental Health Conference at Yale on Oct. 25
Playwright, activist, performer, and feminist Eve Ensler, best known for her play “The Vagina Monologues,” will be the keynote speaker at the first Women’s Mental Health Conference at Yale to be held Friday, October 25, 2019, at Yale School of Medicine, 333 Cedar St.
Becker, Crowley, Esserman & Heapy Win Grant Through NIH HEAL Initiative
Yale School of Medicine (YSM) faculty William C. Becker, MD, associate professor (general internal medicine); Susan Crowley, MD, FASN, professor of medicine (nephrology); and Alicia Heapy, PhD; associate professor of psychiatry; teamed with Yale School of Public Health’s (YSPH) Denise Esserman, PhD, associate professor of biostatistics, were recently awarded a grant for their project, “Video-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving Hemodialysis” through The Helping to End Addiction Long-term, or the NIH HEAL Initiative.
Yale Radiology and Psychiatry Researchers Join with Penn Medicine to Create a New Center to Study Opioid Use Disorders
Opioid use disorder has reached epidemic levels in the United States. Over the last two decades, opioid-related overdose deaths increased by more than 50 percent, with nearly 50,000 in 2018, according to the Centers for Disease Control and Prevention. Researchers from Yale School of Medicine (YSM) and Penn Medicine, which comprises the Perelman School of Medicine at the University of Pennsylvania, have created a new center that focuses on neuroimaging to improve our understanding of opioid use disorders and find new treatments.